# ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II

> **NCT01740895** · — · COMPLETED · sponsor: **Volcano Corporation** · enrollment: 818 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01740895
- **Lead sponsor:** Volcano Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 818 (ACTUAL)
- **Last updated:** 2014-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740895, "ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01740895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*